Thermo Fisher Scientific's PPD Clinical Research Business Expands Bioanalytical Capabilities with New Laboratory in Gothenburg, Sweden
Thermo Fisher Scientific's PPD Clinical Research Business Collaborates with HealthVerity to Expand Real-World Data Capabilities
Lipocine Announces Last Patient Last Visit in Pivotal Phase 3 Trial of LPCN 1154 for Postpartum Depression (PPD)
Lipocine Announces Completion of Enrollment and Dosing in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD)
Lipocine Reports Encouraging Progress Post Second Interim Safety Review in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD)
Thermo Fisher Scientific Launches PPD CorEvitas Alzheimer's Disease Registry to Advance Real-World Evidence in Neurodegenerative Care
Lipocine Highlights Promising Interim Safety Profile in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD)
Lipocine Provides Progress Update on LPCN 1154 Phase 3 Clinical Trial in Postpartum Depression (PPD)
Reunion Neuroscience Announces Positive Topline Results from RECONNECT Phase 2 Clinical Trial of RE104 for the Treatment of Postpartum Depression (PPD)
Reunion Neuroscience Announces Last Patient Dosed in RECONNECT Phase 2 Clinical Trial of RE104 for the Treatment of Postpartum Depression (PPD)
FINAL PPD DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds PDD Holdings Inc. f/k/a Pinduoduo Inc. Investors to Join the Class Action Lawsuit!
ZURZUVAE™ (zuranolone) CIV, a Landmark Oral Treatment for Women with Postpartum Depression (PPD), is Now Available in the U.S.
Brii Biosciences Provides Corporate Update and Reports Full-Year 2022 Financial Results
Thermo Fisher Scientific's PPD Clinical Research Business Earns TOPRA Award for Regulatory Affairs Excellence in Supporting Novavax's COVID-19 Vaccine Approval
Saama Appoints Scott Rogers as Company's Chief Financial Officer
Thermo Fisher Scientific Completes Acquisition of PPD, Inc.
PPD Named to ‘Best Workplaces in Greater China’ for Second Consecutive Year
PPD Named to ‘Best Workplaces in Greater China' for Second Consecutive Year
PPD 连续第二年荣膺2021年度“大中华区最佳职场TM”称号
PPD 連續第二年榮膺2021年度「大中華區最佳職場TM」稱號
PPD Named ‘Best Vaccine CRO of the Year’ in Asia-Pacific
PPD Named ‘Best Vaccine CRO of the Year' in Asia-Pacific
PPD Wins Multiple Awards at Clinical Researcher of the Year Competition
PPD Wins Multiple Awards at Clinical Researcher of the Year Competition
PPD, Inc. (PPD) CEO David Simmons on Q3 2021 Results - Earnings Call Transcript
PPD, Inc. (PPD) Tops Q3 Earnings and Revenue Estimates
PPD Reports Third Quarter and Year-To-Date 2021 Results
PPD Reports Third Quarter and Year-To-Date 2021 Results
Medable Secures $304 Million in Funding at $2.1 Billion Valuation; New Round Co-Led by Blackstone Growth, GSR Ventures and Tiger Global
PPD Named Clinical Research Company of the Year for Second Consecutive Year
PPD Named Clinical Research Company of the Year for Second Consecutive Year
PPD Announces Third Quarter 2021 Earnings Conference Call
PPD Announces Third Quarter 2021 Earnings Conference Call
PPD Announces Third Quarter 2021 Earnings Conference Call
Society for Clinical Research Sites Names PPD Winner of Prestigious Eagle Award
Society for Clinical Research Sites Names PPD Winner of Prestigious Eagle Award
Aethlon Medical Announces Contracting with PPD to Advance Hemopurifier Clinical Programs
PPD Earns Gold Award for Excellence in Employee Learning and Development
PPD Earns Gold Award for Excellence in Employee Learning and Development
PPD Receives Award Recognizing Employee Talent Development
PPD Receives Award Recognizing Employee Talent Development
PPD, Inc. (PPD) CEO David Simmons on Q2 2021 Results - Earnings Call Transcript
PPD, Inc. (PPD) Surpasses Q2 Earnings and Revenue Estimates
PPD Reports Second Quarter and Year-To-Date 2021 Results
PPD Reports Second Quarter and Year-To-Date 2021 Results
PPD Recognized as a Best Place to Work in Asia
PPD Recognized as a Best Place to Work in Asia
PPD Announces Second Quarter 2021 Earnings Conference Call
PPD Announces Second Quarter 2021 Earnings Conference Call